MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$7,776,113
Net Income
$554,586
Net Profit Margin
7.13%
EPS
$0.07
Unit: Dollar
Revenue Breakdown
Processing And Storage Fees
Public Banking
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Revenue
7,776,113
7,683,117
7,934,908.5*
7,825,432
Cost of sales
1,676,663
1,656,488
1,889,711*
1,801,419
Selling, general and administrative expenses
4,617,999
5,011,847
9,288,809.5*
3,876,159
Impairment of investment-Tianhe Stem Cell Biotechnologies Inc
-
-
0*
0
Impairment of public inventory
-
-
1,089,708.5*
-
Research, development and related engineering
99,781
65,761
86,259*
61,625
Depreciation and amortization
184,329
183,887
187,781.5*
185,693
Total costs and expenses
6,578,772
6,917,983
12,542,269.5*
5,924,896
Operating income
1,197,341
765,134
-4,607,361*
1,900,536
Losss (gaines) on marketable securities
72,019
-240,458
53,560*
-193,886
Gain on interest rate swap
-
-
0*
0
Other income
338
8,342
7,238*
17,565
Interest expense
441,917
462,709
432,238.5*
538,219
Total other (expense) income
-369,560
-694,825
-371,440.5*
-714,540
Income before income tax expense
827,781
70,309
-4,978,801.5*
1,185,996
Income tax expense
273,195
23,201
-891,627*
436,588
Net income
554,586
47,108
-4,087,174.5
749,408
Basic EPS
0.07
0.01
-0.507
0.09
Diluted EPS
0.07
0.01
-0.51
0.09
Basic Average Shares
8,055,476
8,055,150
8,068,390
8,057,780
Diluted Average Shares
8,055,476
8,056,133
8,006,957
8,073,654
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Processing And Storage Fees
$7,715,446
Public Banking
$46,485
Product
$14,182
Revenue
$7,776,113
(-1.93%↓ Y/Y)
Operating income
$1,197,341
(-19.78%↓ Y/Y)
Total costs and
expenses
$6,578,772
(2.22%↑ Y/Y)
Income before income
tax expense
$827,781
(43.94%↑ Y/Y)
Total other (expense)
income
-$369,560
(59.72%↑ Y/Y)
Losss (gaines) on
marketable securities
$72,019
(118.99%↑ Y/Y)
Other income
$338
(-97.39%↓ Y/Y)
Selling, general and
administrative expenses
$4,617,999
(8.46%↑ Y/Y)
Cost of sales
$1,676,663
(-9.69%↓ Y/Y)
Depreciation and
amortization
$184,329
(-3.04%↓ Y/Y)
Research, development and
related engineering
$99,781
(-24.24%↓ Y/Y)
Net income
$554,586
(55.88%↑ Y/Y)
Income tax expense
$273,195
(24.57%↑ Y/Y)
Interest expense
$441,917
(-19.82%↓ Y/Y)
Buy us a coffee
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)